But as the women included in this multicenter study were recruited just before the consultation at which they received their test results, our sample can be said to be a non-selected sample representative of the healthy women tested for BRCA1/2 mutations at French cancer genetic clinics. The gene discussed is BRCA1; the disease is cancer.